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1 
TILAK VENKOBA RAO ORATION 
The Tilak Venkoba Rao Oration is for 
the young scientist and before I deliberate 
on my subject it is my honoured right to 
speak for the young psychiatrists in our 
country. I have observed and experienced 
that the young psychiatrist is the most un-
fortunate person during his academic 
career. He is often discouraged from all 
quarters, so much so, that he feels that he 
has to struggle in order to do any work. 
Not to work and not to aspire are the 
easiest ways. The young psychiatrist faces 
numerous uphill obstructions all along and 
perhaps may be frustrated and fall into the 
streamline of complacency and academic 
politicking. For the advancement of our 
discipline and science, undoubtedly, the 
younger scientists have to take lead and 
shoulder the responsibilities. The de-
moralisation, discouragement and the 
crushing of the younger scientists is thus 
very hazardous. In light of these, I feel 
proud and honoured to have been awarded 
this oppurtunity to present my work on 
negative symptoms. No words would be 
sufficient to thank Professor Venkoba Rao 
for having initiated this award, and I would 
like to thank Professor Nandi and the 
judges of the awards committee for this 
award being given to me. I am also grateful 
to numerous collegues who have worked 
with me on negative symptoms. After 
these few words about negative attitudes 
towards young psychiatrists I would pre-
sent my research work on Negative 
Symptoms in Psychiatric disorders. 
In the nineteen eighties there have 
been many subjects which have attracted 
attention, by far maximum research in-
terests have been captured by the study of 
negative symptoms in psychiatric disor-
ders. Psychiatric researchers have taken 
up the challanging task of redefining nega-
tive symptoms, attempts at validating the 
concept and devising measures for their re-
liable quantification. Last and not the 
least, is the unfathomable challenge of the 
treatment of negative symptoms, which 
can be very frustrating. It is really com-
mendable that numerous researchers in 
different parts of the world are concentrat-
ing on a psyehopathological aspect which is 
strife with controversy and challenge. 
Thus the terms positive and negative 
symptoms have slipped into the language 
of contemporary psychiatry with compara-
tive ease. It is not uncommon for these ex-
pressions to be used with little explana-
tion, with the implicit understanding that 
their meaning is understood and that 
somehow they are of value to our know-
ledge of psychopathology (Trimble 1986). 
The concept of negative symptoms is 
both rather old and rather new. Writings of 
Kraeplin (1919) and Bleuler (1950) indicate 
that they had perceived negative or deficit 
symptoms to be the underlying fundamental 
abnormality. Both concluded that, in addi-
tion to a deteriorating course that did not 
permit a full recovery, patients suffering 
from schizophrenia experienced a loss of 
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cognitive, affective, volitional, -and atten-
tional functions. 
The credit for the introduction of these 
terms is usually given to Hughlings Jackson 
and the concept of positive and negative 
symptoms is clearly outlined in several of his 
papers; "'The negative element in the 
symptomatology is what the epileptic dis-
charge produces; it is the dissolu-
tion the positive element is physical 
activity of the lower nervous arrangements, 
which are, except for overactivity, healthy" 
(Jackson 1881). Implicit in these ideas are 
that positive and negative symptoms are 
closely intertwined such that they both occur 
contemporaneously, the pathology that 
gives the negative symptoms at the same 
time allowing expression of the positive 
symptoms. 
The variety of words used to refer to 
the group of negative symptoms highlights 
some of the conceptual problems that re-
main, however. They are variously referred 
to as fundamental, deficit, or negative 
symptoms. "Fundamental" implies that 
they are the basic symptoms in a disorder 
and in some sense pathognomonic of it. The 
word "deficit" implies that these symptoms 
represent a loss of function and sometimes 
imply an irreversible loss as well. The term 
"negative symptoms" is perhaps the least 
specific; it also implies the loss of function, 
but carries no implications about diagnostic 
specificity or irreversibility. Sometimes the 
terms "core negative symptoms" or "Prim-
ary negative symptoms" are used in order to 
identify that subset of negative symptoms 
that are more specific to schizophrenia and 
are probably due to some as yet unrecog-
nized neural mechanism characteristic of 
this illness. 
Methodological Issues: 
In light of the putative clinical and 
theoretical importance of negative 
symptoms and the controversies surround-
ing their assessment, there is a need for 
adequate means of making systematic as-
sessments. 
Measurement: Those interested in this 
area have relied on the analysis of separate 
symptoms and signs, with the notable excep-
tion being the work of Andreason (1981), 
She devised the Scale for the Assessment of 
Negative symptoms (SANS) which has sub-
sequently been widely used in U.S., India, 
and Europe. Lewine and colleagues (1984) 
used data obtained from well established 
psychiatric instruments administered regu-
larly and used the Rasch model in the con-
struction procedure in the development of 
the symptom scale. They derived items from 
the Schedule for Affective disorders and 
Schizophrenia-current (SADS-C) and the 
Nurses' Observation Scale for Inpatient 
Evaluation (NOSIE). Many researchers 
have used the Brief Psychiatric Rating scale 
items for assessing negative symptoms. 
Other instruments which have been used for 
assessment of negative symptoms are the 
Krawiecka scale, Psychopathology Rating 
scale and the Psychiatric Assessment Inter-
view, PAL In most of my research on nega-
tive symptoms I have used Andreason's Scale 
for Assessment of Negative symptoms. 
Reliability and Validity: The validity of 
SANS was reported by Andreasen and 
Oslen (1982). There was good internal con-
sistency for items as well as subscales. The 
interrater and test—retest reliability was as-
sessed in the Indian set up, and found to be 
reasonably high on most components by us 
(Mathaietal. 1984). 
Stability of Negative Symptoms: We 
found negative symptoms to remain stable 
over a period of one month (Mathai et al. 
1984) and even after a period of two years 
(Michael et al. 1986) in a group of patients 
diagnosed as chronic schizophrenia. The 
stability of negative symptoms in chronic 
schizophrenics could partly be due to lack of 
adequate treatment models presently. 
Prevalence and nature of negative 
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considered important clinical features of 
schizophrenia, they are neither pathog-
nomonic of it, nor specific to it. Their fre-
quency in other psychiatric illnesses, as de-
pression has been reported by many work-
ers (Andreasen and Akiskal 1983, Pogue-
Geile and Harrow 1984, Chaturvedi and 
Sarmukaddam 1985, a). In manic and 
acute schizophrenic episodes also negative 
symptoms have been described. High 
negative symptom scores were also ob-
served in simple schizophrenics, 
schizotypal personality disorder cases and 
mentally retardates. 
In our study of 30 chronic schizop-
hrenics, according to DSM III diagnosis, 
mild negative symptoms rated on SANS 
were observed in more than 75% of the 
cases and severe intensity of negative 
symptoms were noted in nearly 2/3 of the 
cases, and fulfilled the criteria of Negative 
Schizophrenia as described by Andreasen 
and Oslen (1982) (Chaturvedi et al. 1984). 
Lindenmayer et al. (1984) reported predo-
minant negative symptoms in nearly 25% 
of acute schizophrenic patients. We had 
also observed that some acute schizop-
hrenics did have marked negative 
symptoms, especially affective flattening, 
impaired attention and poverty of speech. 
Study of negative symptoms in depre-
ssive disorders has also attracted attention, 
though not to the same extent as for 
schizophrenia. Pogue Geile and Harrow 
(1984) have reported mild negative 
symptoms in depressives after an lV4 year 
follow up. Interestingly, the frequency, 
nature and prognostic value of some nega-
tive symptoms have been examined earlier 
in neurotic and psychotic depression cases, 
though these symptoms were not termed 
as negative symptoms, then. Andreasen 
(1986) also reported marked negative 
symptoms in patients diagnosed as major 
depression. In a study on 34 patients diag-
nosed as definite, endogenous major de-
pression according to R.D.C. (Spitzer 
1978) we found high mean scores on each 
of the SANS subscales. The commonest 
negative symptoms were inability of enjoy 
recreational activities and interests (77%), 
inability to enjoy sexual activity and in-
terest (65%), feeling of anhedonia (62%), 
inability to form friendship and physical 
anergia (56% each). The negative 
symptoms were more marked in the 
younger patients (Chaturvedi and Sar-
mukaddam 1985). 
Negative symptoms have recently 
been studied in mania also and differences 
in negative symptoms between patients 
diagnosed as schizophrenia, mania and de-
pression have been documented by An-
dreasen (1986). We had examined the dif-
ferences in negative symptoms between 
chronic schizophrenics and major en-
dogenous depressions and found that total 
negative symptom score and affective flat-
tening were higher in the schizophrenic 
group than depressives. Depressives were 
more often subjectively aware of the nega-
tive symptoms and more often had feelings 
of anhedonia, avolition and affective flat-
tening (Chaturvedi et al. 1985). In cases of 
severe neurotic depression we did not find 
negative symptoms to occur commonly. 
PSYCHOBIOLOGICAL ASPECTS 
Neurological abnormalities: Crow (1980) 
has proposed an anatomical model for 
negative symptoms in which negative 
symptoms (Crow's Type II symptom syn-
drome) represent a behavioural manifesta-
tion of some structural brain abnormality, 
such as cortical atrophy. Several studies 
have explored this hypothesized associa-
tion between negative symptoms and ven-
tricular enlargement on computed tomog-
raphy scans (Johnstone et al. 1976, An-
dreasen et al. 1976, Nasrallah et al. 1983) 
and other biological variables, such as 
platelet monoamine oxidase (Lewine and 16  NEGATIVE SYMPTOMS IN PSYCHIATRY 
Meltzer 1984), with somewhat mixed re-
sults. Studies have been generally more 
unequivocal in finding negative symptoms 
to be associated with intellectual deficits in 
chronic schizophrenic patients (Johnstone 
et al. 1981, Owens and Johnstone 1980). 
Crow (1980) has suggested that positive 
symptoms (his type I symptom syndrome) 
may be caused by a fluctuating, functional 
dopamine excess, in contrast with the 
structural brain abnormality hypothesized 
to underlie negative symptoms. 
In one of our study conducted on 30 
patients diagnosed as schizophrenia by 
DSM III Criteria (A.P.A. 1980), 15 each 
with predominantly positive and negative 
symptoms, it was found that negative 
schizophrenics had a significantly higher 
prevalence of 'soft' neurological' signs, 
especially, with regard to, frontal, 
parietal, temporal and total lobe scores 
(Mathews et al. 1985). 
C. T. Scan abnormalities: Dilated 
ventricles and enlarged sulci have been 
found in patients with predominant nega-
tive symptoms (Crow 1982. Seidman 
1983). Enlargement of the third ventricle 
has also been noted. However, no defini-
tive or pathognomonic abnormality has 
been observed in chronic schizophrenics -
either those with positive or with negative 
symptoms. 
Cognitive Dysfunction: Waddington 
et al. (1985) have in a series of studies 
documented close relationship between 
tardive dyskinesia, intellectual impair-
ment and negative symptoms in schizop-
hrenics. The prominent negative symptom 
in such patients is usually poverty of 
speech. Negative schizophrenics have 
been found to have more dysfunctions, 
especially in the elderly. However, 
there are no indications of gross deteriora-
tion of cognitive functions. A few studies 
have found almost similar disturbances in 
schizophrenics with mainly positive 
symptoms. Signal discrimination attention 
deficits on psychometric tests were consis-
tently associated with negative symptoms 
(Nuechterlain et al. 1986). A possible 
theoretical link between schizophrenic at-
tentional impairment and negative 
symptoms derives from the recent sugges-
tion that the pattern of deficits in atten-
tional functioning and information proces-
sing in schizophrenic patients is consistent 
with a reduction in available processing 
capacity (Neuchterlain and Dawson 1984). 
In our study, chronic schizophrenics who 
were older in age, had longer duration of 
illness and continued medications had sig-
nificantly higher attentional impairment 
than others (Chaturvedi et al. 1985). 
Language Production: Allen (1983) 
found that contrary to existing conceptions 
of speech disorder in schizophrenia, both 
positive and negative speech disorder were 
found to be marked by poverty of thought, 
as measured by production of fewer and 
shorter ideas and lower speech variability. 
In another study on 45 R.D.C. Schizop-
hrenics, positive and negative thought dis-
orders were equally present in acute and 
chronic schizophrenics, and paranoid and 
non—paranoid schizophrenics (Mazumdar 
and Chaturvedi 1987). 
Pre-Morbid Adjustment: There have 
been definite indications of early develop-
mental delay in milestones, poor scholastic 
performance, and poor premorbid adjust-
ment in patients with prominent negative 
symptoms. In our study comparing posi-
tive with negative schizophrenia, though a 
predominance of poor premorbidity was 
noted, there were no significant differ-
ences between the positive symptoms and 
negative symptoms groups (Mathews, 
Chaturvedi & Gopinath 1986) 
Intellectual impairment: Though no 
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observed in patients with negative 
symptoms, certain studies did find that pa-
tients with negative symptoms had intel-
lectual impairment especially in patients 
who had demonstrable structural brain 
damage (Waddington et al. 1986). Patients 
with negative symptoms tend to have 
lower educational achievements than 
those with positive symptoms. 
Dyskinetic Movements: Patients with 
dyskinetic orofacial movements, more 
often had negative symptoms, especially in 
the elderly (Waddington et al. 1985). In 
another recent study, almost two-thirds of 
patients with tardive dyskinesia had high 
negative symptom scores (Karson et al. 
1985). These findings support the proposal 
that, at least in schizophrenia, subtle or-
ganic changes may contribute to vulnera-
bility to the emergence of involuntary 
movements as well as negative symptoms 
(Waddington and Youssef 1986, Crow 
1980). 
Neurotransmitters Disturbances: 
There has been relatively little investiga-
tion of the biological correlates of nega-
tives symptoms. Certain researchers have 
proposed that the mechanisms underlying 
negative symptoms could be neurochemi-
cal and therefore potentially reversible. 
Negative symptoms may be due to a func-
tional deficit in dopamine rather than an 
excess. Crow et al. (1981) have shown that 
while the number of D2 receptors is de-
creased in patients with positive 
symptoms, patients With negative 
symptoms have normal numbers of D2 re-
ceptors. The enzymes Dopamine beta hyd-
roxylase and Choline acetyl transferase 
were not found to be reduced in patients 
with negative symptoms (Crow et al. 
1981). 
Lewine and Meltzer (1984) had ob-
served an association between high 
platelet MAO activity and negative 
symptoms in male patients, thereby possi-
bly implicating the Serotonin system. 
However, such a relationship was not ob-
served in the studies of Owen et al. (1981) 
and Brockington et al. (1976). 
Other reports observed decreased 
cholecystokinin content in the hippocam-
pus and amygdala and stomatostatin con-
tent in the hippocampus of patients with 
prominent negative symptoms. Since 
Cholecystokinin (CCK) and dopamine 
coexist in the mid brain as co-transmitters, 
this finding could provide further support 
for dopaminergic involvement. Also since 
CCK and stomatostatin are located in 
amygdalo-hippocampal projections, and 
in hippocampus in small interneurons 
these changes may reflect local neuronal 
loss (Ferrier et al. 1983, Roberts et al. 
1983). 
However, a number of studies did not 
find any relationship between platelet 
MAO activity and negative symptoms. Sex 
hormones have also been implicated to 
have a role in the modulation of both 
platelet MAO activity and negative 
symptoms in the same direction. 
Other parameters which have been in-
vestigated are the Dexamethasone sup-
pression tests and smooth purusit eye 
movements in patients with and without 
negative symptoms. Shima et al. (1986) 
found post dexamethasone Cortisol levels 
to be significantly correlated with the 
SANS total scores and the non-suppres-
sors were all classified as 'negative schizop-
hrenia'. 
Neuropsychological Defects: Patients 
with prominent negative symptoms have 
been found to have impairment in neurop-
sychological testing. The pattern of 
neuropsychological deficits appeared to be 
consistent with a process characterized by 
failure in the development of a normal re-
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Negative symptoms have also been 
found to be associated with lowered informa-
tion processing capacity, as already described. 
EEG Abnormalities: Though a few re-
ports had mentioned about non-specific 
EEG abnormalities in patients with negative 
symptoms, no such difference was observed 
by us (Mathews, Chaturvedi and Gopinath 
1986). We, however, found abnormalities of 
EEG equally distributed in both the positive 
and negative symptom groups. 
Pharmacological basis of negative 
symptoms: Drug side effects may mimic 
negative symptoms e.g. akinesia. Al-
though not well established there is a po-
tentially more fundamental relationship 
between neuroleptic drug action and nega-
tive symptoms. Psychological and be-
havioural changes similar to negative 
symptoms have been induced in infrahu-
man primates and non-psychotic humans 
by neuroleptic drugs. Although neurolep-
tics do not produce neuroanatomical le-
sions, noradrenergic receptor blockade by 
these drugs would theoretically be func-
tionally equivalent, and, as such, might 
produce negative symptoms like 
anhedonia by a similar mechanism. We 
had observed that certain negative 
symptoms as inattention, social with-
drawal and affective flattening were aggra-
vated by continuous neuroleptic therapy 
(Chaturvedi et al. 1985, Chaturvedi 1986). 
PSYCHOSOCIAL ASPECTS 
Social understimulation and in-
stitutionalization are other factors consi-
dered as influencing production of nega-
tive symptoms. Hospital environment has 
also been blamed to have a role in exacer-
bating negative symptoms or deficits as av-
olition and apathy. Andreasen and Oslen 
(1982) and we in our study on chronic 
schizophrenia (Chaturvedi et al. 1984) 
however did not note similar observations. 
However, the understanding of psycholog-
ical and psychosocial factors in negative 
symptoms has received little attention. 
Carpenter et al. (1985) have described that 
the trauma experienced by the person with 
schizophrenia and the possible psychologi-
cal reactions to that experience, and fac-
tors like demoralisation may be crucial in 
many instances of negative symptons. 
Currently, phenomenon such as de-
moralization and source of "low energy" 
or poor goal orientation in schizophrenia 
receive only little attention. The possible 
roles of social supports, self esteem, hope, 
coping mechanisms and their aberrations 
are all crucial pieces for understanding 
negative symptoms and for their preven-
tion and treatment. 
We studied a large group of patients 
attending day care services and found that 
they showed improvement in negative 
symptoms, and about 45% showed reason-
ably adequate work performance as com-
pared to other schizophrenics. Also their 
duration of stay in day care centre is com-
parable to other psychiatric patients 
(Gopinath et al. 1985, Chaturvedi et al. 
1986). In yet another interesting study we 
constructed a scale for the assessment of 
Family Distress, due to an individuals 
symptoms. We found that negative 
symptoms were more often perceived as 
distressful as compared to positive 
symptoms (Gopinath and Chaturvedi 
1986). 
Duration of hospitalisation of chronic 
schizophrenics did not have any significant 
relationship with the severity of negative 
symptoms or subscale scores (Chaturvedi 
et al. 1985). 
Cultural Differences: These were first 
noted in the multicentred International 
Pilot study of Schizophrenia and its 2-year SANTOSH K. 
follow-up. Negative symptoms were not 
specifically studied in these investigations. 
Recently, we have compared nature, sev-
erity and prevalence of negative symptoms 
in schizophrenics in India and U.S. where 
similar instruments and methods have 
been employed. Significant differences are 
noted with regard to speech related nega-
tive symptoms. Similar comparison for pa-
tients with major depression also showed 
that negative symptoms occur in different 
cultures, but the type differ depending on 
the cultural background (Chaturvedi 
1986a). 
Prognostic Value of Negative Symptoms: 
Schizophrenia: Most studies have 
clearly documented poor prognosis of 
schizophrenia in those who have predomi-
nent negative symptoms (Johnstone et al. 
1981, Andreasen and Oslen 1982). In 
India, we have also made similar observa-
tions in chronic schizophrenics. This is 
more related to the underlying brain dam-
age, which coexists (Chaturvedi et al. 
1984). 
Depression: Depressives with promi-
nent negative symptoms and anhedonia 
had been found to require a longer dura-
tion of treatment, had a poorer outcome, 
and also they required adjuvants as anti-
psychotics and electroconvulsive therapies 
in addition to antidepressants (Chaturvedi 
and Sarmukaddam 1985; 1986a; 1986b). 
Negative symptoms have thus been found 
to have definitely a detrimental influence 
on the outcome of depression. Retarded 
depressives are usually believed to have a 
favourable outcome, but our studies on en-
dogenous depression, revealed that high 
initial negative symptom scores, unrelated 
to severity of depression, predicted poorer 
outcome at one year follow-up. Long term 
follow-ups also indicate presence of nega-
tive symptoms in sub-chronic or chronic 
forms of depression (Andreasen and Akis-
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kal, 1983). The prognostic value of nega-
tive symptoms in other disorders is still 
under study. 
Conclusions 
The concept of negative symptoms 
has become increasingly important since 
it was reintroduced into psychiatric 
thinking several years ago. As the possi-
ble significance of negative symptoms 
clarified, the complexity of this concept 
has also become apparent. Genetic, 
other biological, and many psychosocial 
factors may interact over time in impor-
tant ways to generate negative 
symptoms. It does not seem possible now 
to provide an integration of the vast 
number of considerations and com-
plexities that the focus on negative 
symptoms has generated. The various 
pathways for understanding these 
symptoms have become clearer, how-
ever, and with this clarity is the increas-
ing possibility of improved prevention 
and control of these tragic and debilitat-
ing phenomenon. 
While theoretically appealing, and 
while supported by considerable evi-
dence, the distinction between positive 
and negative symptoms in schizophrenia 
have a number of problems. It is best vie-
wed as a heuristic approach to subtyping 
schizophrenia that lends itself to 
hypothesis testing and may be hypothesis 
generating. There is a possibility that a 
distinct category of 'negative depression' 
also occurs, which needs confirmation. 
The etio-pathogenesis of negative 
symptoms is still unclear, though the role 
of structural brain damage, neurochemi-
cal mechanism and psychosocial factors 
have been well recognised. Similarly, the 
treatment aspects still require definitive 
trials for the alleviation of negative 
symptoms. 20  NEGATIVE SYMPTOMS IN PSYCHIATRY 
Future Developments 
In dealing with the complex issues 
related to negative symptoms major 
progress has been made in describing 
negative symptoms more reliably and in 
taking steps toward identifying possible 
biological correlates. Besides pursuing 
further the biological aspects two other 
particularly important directions need to 
be pursued. 
First, the psychosocial factors need 
to be explored further both in terms of 
their etiological contributions to nega-
tive symptoms and in the way these 
symptoms influence psychosocial aspects 
of the evolution of the disorder and re-
covery. 
Secondly, more attention must be 
focussed on the potential that negative 
symptoms have for providing an under-
standing of the interface between biolog-
ical, psychological and social processes in 
psychiatric disorders. In these ways the 
study of negative symptoms may contri-
bute major clues to the nature of 
psychopathology, its etiologies and its 
course. 
Treatment of Negative Symptoms 
The rational for treatment of the 
negative symptoms of schizophrenia re-
quires a careful differentiation of those 
secondary to a range of other factors and 
those that constitute enduring primary or 
deficit symptoms. Secondary negative 
symptoms are usually responsive to treat-
ment of the underlying cause. In contrast, 
there is no intervention currently available 
with established efficacy in treating deficit 
symptoms, or the primary negative 
symptoms (Carpenter et al. 1985). 
Various drugs which have been used 
for the treatment of negative symptoms in-
clude neuroleptics, anticholinergic agents, 
anti-depressants, anxiolytics, am-
phetamines, L-dopa, etc., Other methods 
include reducing dosage of neuroleptics. 
Other modes of therapies like suppor-
tive therapy, psychotherapy, activity 
therapy, skills training can be tried. There 
are no well established evidences to sup-
port the use of these techniques. It is the 
challanging task of reducing these negative 
symptoms in psychiatric disorders which 
makes the subject so interesting. 
Rehabilitation measures and after 
care services also probably could be useful 
in minimising negative symptoms. 
Critique: 
Recently there has been a revival of 
interest in the study of negative symptoms. 
Most researchers have quite emphatically 
pointed out that negative symptoms are 
not indigenous or characteristic of schizop-
hrenia and are seen in other psychotic dis-
orders and depression as well. 
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